Inhibition of breast cancer growth and invasion by single-minded 2s.
暂无分享,去创建一个
R. Metz | W. Porter | P. Schedin | Hyeong-il Kwak | T. Gustafson | B. Laffin | Pepper Schedin | Brian Laffin | Hyeong-Il Kwak | Tanya Gustafson | Richard P Metz | Weston W Porter
[1] R. Narayanan,et al. Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Loda,et al. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. , 2005, The Journal of biological chemistry.
[3] J. Merrick,et al. Cancer incidence in persons with Down syndrome in Israel. , 2002, Down's syndrome, research and practice : the journal of the Sarah Duffen Centre.
[4] J. Pelletier,et al. Characterization of msim, a murine homologue of the Drosophila sim transcription factor. , 1996, Genomics.
[5] J. Hogenesch,et al. The PAS superfamily: sensors of environmental and developmental signals. , 2000, Annual review of pharmacology and toxicology.
[6] H. Hasle,et al. [Incidence of cancer in individuals with Down syndrome]. , 2000, Tidsskrift for Den Norske Laegeforening.
[7] Massimo Loda,et al. Caveolin-1 Promotes Tumor Progression in an Autochthonous Mouse Model of Prostate Cancer , 2005, Journal of Biological Chemistry.
[8] M. Lisanti,et al. Caveolin-1 in oncogenic transformation, cancer, and metastasis. , 2005, American journal of physiology. Cell physiology.
[9] Ming You,et al. Wildtype Kras2 can inhibit lung carcinogenesis in mice , 2001, Nature Genetics.
[10] H. Hasle,et al. Risks of leukaemia and solid tumours in individuals with Down's syndrome , 2000, The Lancet.
[11] M. Passos-Bueno,et al. High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours , 2001, European Journal of Human Genetics.
[12] Z. Werb,et al. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression [published erratum appears in J Cell Biol 1996 Feb;132(4):following 752] , 1994, The Journal of cell biology.
[13] Patricia Keating,et al. Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] L. Matrisian,et al. TEL, a Putative Tumor Suppressor, Modulates Cell Growth and Cell Morphology of Ras-Transformed Cells While Repressing the Transcription of stromelysin-1 , 2000, Molecular and Cellular Biology.
[15] R. Narayanan,et al. Down's syndrome-associated single minded gene as a novel tumor marker. , 2002, Anticancer Research.
[16] Carole Mathelin,et al. Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression. , 2003, Cancer research.
[17] T. Golub,et al. The Six 1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A 1 , 2004 .
[18] R. Narayanan,et al. Down's syndrome-associated Single Minded 2 gene as a pancreatic cancer drug therapy target. , 2003, Cancer letters.
[19] H. Moon,et al. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. , 2001, Cancer research.
[20] J. Nelson,et al. Caveolin expression is decreased following androgen deprivation in human prostate cancer cell lines , 1999, The Prostate.
[21] S. Antonarakis,et al. Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (Sim2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of Down syndrome. , 2000, Human molecular genetics.
[22] K. Miyazaki,et al. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells , 2004, British Journal of Cancer.
[23] Takahide Kohro,et al. Vascular Endothelial Growth Factor- and Thrombin-induced Termination Factor, Down Syndrome Critical Region-1, Attenuates Endothelial Cell Proliferation and Angiogenesis*♦ , 2004, Journal of Biological Chemistry.
[24] M. Sundaram,et al. The love-hate relationship between Ras and Notch. , 2005, Genes & development.
[25] G. Murphy,et al. Functional Significance of MMP-9 in Tumor Necrosis Factor-Induced Proliferation and Branching Morphogenesis of Mammary Epithelial Cells. , 2000, Endocrinology.
[26] V. Band,et al. Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells , 1991, Journal of virology.
[27] A. Sasco,et al. An excess of testicular germ cell tumors in down's syndrome , 1997, Cancer.
[28] M. Duffy,et al. Ets2 transcription factor in normal and neoplastic human breast tissue. , 2006, European journal of cancer.
[29] T. Golub,et al. The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[30] D. Lovett,et al. Tumour metastasis suppressor, nm23-beta, inhibits gelatinase A transcription by interference with transactivator Y-box protein-1 (YB-1). , 2002, The Biochemical journal.
[31] O. Gotoh,et al. cDNA cloning of a murine homologue of Drosophila single-minded, its mRNA expression in mouse development, and chromosome localization. , 1996, Biochemical and biophysical research communications.
[32] B. Modan,et al. Incidence of leukemia and other cancers in Down syndrome subjects in Israel , 2001, International journal of cancer.
[33] Z. Werb,et al. Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1. , 1995, Seminars in cancer biology.
[34] John N. Hutchinson,et al. Caveolin-1 Gene Disruption Promotes Mammary Tumorigenesis and Dramatically Enhances Lung Metastasis in Vivo , 2004, Journal of Biological Chemistry.
[35] J. Pelletier,et al. The murine Sim-2 gene product inhibits transcription by active repression and functional interference , 1997, Molecular and cellular biology.
[36] Z. Werb,et al. Stromelysin-1 Regulates Adipogenesis during Mammary Gland Involution , 2001, The Journal of cell biology.
[37] M. Barbacid,et al. RAS oncogenes: the first 30 years , 2003, Nature Reviews Cancer.
[38] Hans Clevers,et al. Notch1 functions as a tumor suppressor in mouse skin , 2003, Nature Genetics.
[39] Edgar D Staren,et al. Matrix metalloproteinase expression in breast cancer. , 2003, The Journal of surgical research.
[40] R. Metz,et al. Differential Transcriptional Regulation by Mouse Single-minded 2s* , 2006, Journal of Biological Chemistry.
[41] S. Chakraborti,et al. Regulation of matrix metalloproteinases: An overview , 2003, Molecular and Cellular Biochemistry.
[42] Sven Cnattingius,et al. Mortality and cancer incidence among individuals with Down syndrome. , 2003, Archives of internal medicine.
[43] G. Dotto,et al. High commitment of embryonic keratinocytes to terminal differentiation through a Notch1-caspase 3 regulatory mechanism. , 2004, Developmental cell.
[44] M. Lupien,et al. Tumorigenesis and Neoplastic Progression Overexpression of Activated Murine Notch 1 and Notch 3 in Transgenic Mice Blocks Mammary Gland Development and Induces Mammary Tumors , 2022 .
[45] R. Arceci,et al. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome. , 2003, Blood cells, molecules & diseases.
[46] Bing Zhang,et al. Presence of the Acute Phase Protein, Bikunin, in the Endometrium of Gilts During Estrous Cycle and Early Pregnancy1 , 2001, Biology of reproduction.
[47] M. L. Beau,et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome , 2002, Nature Genetics.
[48] A. Sasco,et al. Another reason to look for tumor suppressor genes on chromosome 21 , 1998, Genes, chromosomes & cancer.
[49] 三好 篤. Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma , 2005 .
[50] S. Antonarakis,et al. Cloning of two human homologs of the Drosophila single-minded gene SIM1 on chromosome 6q and SIM2 on 21q within the Down syndrome chromosomal region. , 1997, Genome research.
[51] J. Connolly,et al. Tumor progression in four mammary epithelial cell lines derived from the same patient. , 1990, Cancer research.
[52] V. Cavaillès,et al. Estrogen receptor cofactors expression in breast and endometrial human cancer cells , 1999, Molecular and Cellular Endocrinology.
[53] D. Satgé,et al. Down's syndrome protects against breast cancer: Is a constitutional cell microenvironment the key? , 2005, International journal of cancer.
[54] M. Katsuki,et al. Mild impairment of learning and memory in mice overexpressing the mSim2 gene located on chromosome 16: an animal model of Down's syndrome. , 1999, Human molecular genetics.
[55] I. Pucci‐Minafra,et al. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera , 2004, British Journal of Cancer.
[56] R. Perez-soler,et al. Complex effects of Ras proto-oncogenes in tumorigenesis. , 2003, Carcinogenesis.
[57] M. Duffy,et al. Overexpression of the Ets-1 transcription factor in human breast cancer , 2004, British Journal of Cancer.